This episode features David J. Fong, PharmD, former retail pharmacy senior executive who is now president of Dave Fong Rx Consulting, Inc., discussing trends and top opportunities likely to impact the retail pharmacy industry in the coming year, including:
- DIR fees
- Pharmacist provider status
- Hospital-retail partnerships
- Opioid epidemic
You may also like:
Two years ago, I wrote a blog about health information exchange (HIE) and the role of the pharmacist in this important co...
As the U.S. Department of Health and Human Services (HHS) focuses its attention on drug pricing, a pharmacy advocacy group is urging HHS leadership not to ignore the issues presented by direct and indirect remuneration (DIR) fe...
Stay in the Know
Sign up to start receiving notifications via email of our upcoming webinars!